Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02792582 · ClinicalTrials.gov registry record · Phase 2
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
A Phase 2 study of Craniopharyngioma, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT02792582 is a Phase 2 study of Craniopharyngioma that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 160 participants, below the 190-participant average among 6 other Craniopharyngioma trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02792582, a Phase 2 study of Craniopharyngioma, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Craniopharyngioma is a rare brain tumor that affects both children and adults. It arises in a region of the brain near the pituitary gland, visual pathways, and central blood vessels. Patients often present with headache, loss of vision or delayed growth. In some instances they may present with imbalance of water and salts in the body. The treatment for craniopharyngioma may be radical surgery or a combination of surgery and radiation therapy. In some instances surgery is not required. If the tumor cannot be completely removed, radiation therapy may be required. In this study we will use the most advanced form of proton therapy which is called intensity-modulated proton therapy. This is a newer form of radiation therapy which has a number of advantages over older forms of proton therapy and conventional radiation therapy using x-rays. The main goal of this study is to learn if proton therapy will effectively treat patients with craniopharyngioma brain tumors and reduce side effects compared to more traditional forms of radiation therapy.
Conditions Studied
Interventions
- PROCEDURE Surgery
- RADIATION Proton Therapy
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-06-22 |
| Est. Completion | 2028-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02792582
The ClinicalTrials.gov registry entry for NCT02792582 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 6 other Craniopharyngioma trials with a reported enrollment target (16% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Craniopharyngioma appearing as the primary indexed condition, and to 2 interventions - of which Surgery is the first listed.
NCT02792582 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02792582 about?
NCT02792582 is a clinical study titled "A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection". Craniopharyngioma is a rare brain tumor that affects both children and adults. It arises in a region of the brain near the pituitary gland, visual pathways, and central blood vessels. Patients often present with headache, loss of vision or delayed growth. In some instances they may present with imba...
What is the current status of trial NCT02792582?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2016-06-22. Estimated completion is 2028-12.
What conditions does trial NCT02792582 study?
This clinical trial studies the following conditions: Craniopharyngioma.
What interventions are being tested in trial NCT02792582?
The interventions under investigation include: Surgery (PROCEDURE), Proton Therapy (RADIATION).
Who is sponsoring clinical trial NCT02792582?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02792582 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Craniopharyngioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
RECRUITING · Phase 2
-
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
RECRUITING · Phase 2
-
Methionine PET/CT Studies In Patients With Cancer
ACTIVE NOT RECRUITING · Phase 2
-
A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
ACTIVE NOT RECRUITING · Phase 2
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.